您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
Alexa Fluor® 488 Mouse Anti-Human CD62P Antibody (S-921-3)

Alexa Fluor® 488 Mouse Anti-Human CD62P Antibody (S-921-3)

货号: S0B1616
价格: 650
规格: 20T
介绍: -
其他: -
产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD62P
  • 分子别名

    P-selectin; CD62 antigen-like family member P; Granule membrane protein 140 (GMP-140); Leukocyte-endothelial cell adhesion molecule 3 (LECAM3); Platelet activation dependent granule-external membrane protein (PADGEM); SELP; GMRP; GRMP
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Cell membrane
  • Accession

    P16109
  • 克隆号

    S-921-3
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1,k
  • 应用

    FCM
  • 反应种属 ?

    Hu
  • 阳性样本

    human PBMC
  • 纯化方式

    Protein G
  • 浓度

    0.2mg/ml
  • 标记

    Alexa Fluor® 488
  • 性状

    Liquid
  • 缓冲体系

    PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
稀释度
应用 稀释度 推荐种属
FCM 5 μl per million cells in 100μl volume Hu
背景介绍
  • CD62P is a type-1 transmembrane protein that in humans is encoded by the SELP gene. It functions as a cell adhesion molecule (CAM) on the surfaces of activated endothelial cells, which line the inner surface of blood vessels, and activated platelets. In unactivated endothelial cells, it is stored in granules called Weibel-Palade bodies. CD62P plays an essential role in the initial recruitment of leukocytes (white blood cells) to the site of injury during inflammation. When endothelial cells are activated by molecules such as histamine or thrombin during inflammation, CD62P moves from an internal cell location to the endothelial cell surface. P-selectin is also very important in the recruitment and aggregation of platelets at areas of vascular injury. CD62P has a functional role in tumour metastasis similar to E-selectin. CD62P is expressed on the surface of both stimulated endothelial cells and activated platelets, and helps cancer cells invade into the bloodstream for metastasis and provides local multiple growth factors, respectively.